Filing Details
- Accession Number:
- 0001209191-21-057037
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-09-21 16:30:30
- Reporting Period:
- 2021-09-20
- Accepted Time:
- 2021-09-21 16:30:30
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1762303 | Avita Medical Inc. | RCEL | Surgical & Medical Instruments & Apparatus (3841) | 202578762 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1816242 | Suzanne Crowe | C/O Avita Therapeutics, Inc. 28159 Avenue Stanford, Suite 220 Valencia CA 91355 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-09-20 | 1,066 | $17.08 | 4,112 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- Reflects 5,330 of the Issuer's CHESS Depositary Interests ("CDIs"). CDIs are units of beneficial ownership in shares of common stock of the Issuer that are publicly traded on the Australian Securities Exchange (the "ASX") and held by CHESS Depositary Nominees Pty, Limited, a subsidiary of ASX Limited, the company that operates the ASX. Five CDIs are equivalent to one share of the Issuer's common stock and have all the rights and privileges of common stock.
- The purchase price was converted from A$4.72, using the exchange rate as in effect on the date of the transaction, and reflects the 5:1 consolidation ratio applied in converting CDIs to shares of the Issuer's common stock.
- The Reporting Person holds 20,560 CDIs, which translate into the 4,112 shares of common stock set forth above.